PRAIS 2.0 – Página 356 – Plataforma Regional sobre Acceso e Innovación para las Tecnologías de la Salud

RT @WHO: If testing is not possible, #COVID19 quarantine period can still be reduced for contacts who do not develop

admin - 14:04, 17 de febrero de 2022398

RT @WHO: If testing is not possible, #COVID19 quarantine period can still be reduced for contacts who do not develop symptoms after, for ex…

twitter-es

RT @WHO: Where #COVID19 contact tracing capacity is overstretched, countries may need to focus on suppressing severe disease & reducing

admin - 14:04, 17 de febrero de 2022375

RT @WHO: Where #COVID19 contact tracing capacity is overstretched, countries may need to focus on suppressing severe disease & reducing dea…

twitter-es

RT @WHO: NEW: WHO guidance on contact tracing and quarantine for places with extremely high cases due to #COVID19 variant

admin - 14:02, 17 de febrero de 2022408

RT @WHO: NEW: WHO guidance on contact tracing and quarantine for places with extremely high cases due to #COVID19 variant of concern Omicro…

twitter-es

🚨 "We need to act quickly and decisively to save lives. ➡️This will not be the last variant ⬅️, and

admin - 11:39, 17 de febrero de 2022485

🚨 "We need to act quickly and decisively to save lives. ➡️This will not be the last variant ⬅️, and the future of the pandemic is still extremely uncertain" @DirOPSPAHO #COVID19 https://t.co/NVKdDTJHi2

twitter-es

Outpatient appointments 👨‍🔬👩‍⚕️ help monitor health conditions during the first days of life 👶 and clarify any doubts about a

admin - 11:21, 17 de febrero de 2022486

Outpatient appointments 👨‍🔬👩‍⚕️ help monitor health conditions during the first days of life 👶 and clarify any doubts about a newborn's health.

Learn more about newborn care
👉 bit.ly/34f92nC

#first28days  #NewbornHealt https://t.co/0XZbNdMSmm

twitter-es

RT @campusvirtualsp: 👀❗️Are you interested in improving the quality of research for health or increasing the usability of reports for

admin - 11:17, 17 de febrero de 2022536

RT @campusvirtualsp: 👀❗️Are you interested in improving the quality of research for health or increasing the usability of reports for decis…

rss-es

Do Not Use E25Bio COVID-19 Tests: FDA Safety Communication

Murilo Freitas - 05:00, 17 de febrero de 2022491

The FDA is warning people not to use the E25Bio COVID-19 Direct Antigen Rapid Test. The FDA is concerned about the risk of false results when using this test.

http://www.fda.gov/medical-devices/safety-communications/do-not-use-e25bio-covid-19-tests-fda-safety-communication

rss-es

Family Dollar Stores Issues Voluntary Recall of Certain FDA-Regulated Products in Six States Including Drugs, Devices, Cosmetics, Foods

Murilo Freitas - 05:00, 17 de febrero de 2022473

Family Dollar,
Inc. is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and shipped to 404 stores from Family Dollar Distribution Center 202 in West Memphis, Arkansas from January 1, 2021 through the pre

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-dollar-stores-issues-voluntary-recall-certain-fda-regulated-products-six-states-including

rss-es

E25Bio Recalls COVID-19 Direct Antigen Rapid Tests That Are Not Authorized, Cleared, or Approved by the FDA and May Give False Results

Murilo Freitas - 05:00, 17 de febrero de 2022472

E25Bio COVID-19 Direct Antigen Rapid Tests are being recalled because they are not authorized, cleared, or approved for use by the FDA.

http://www.fda.gov/medical-devices/medical-device-recalls/e25bio-recalls-covid-19-direct-antigen-rapid-tests-are-not-authorized-cleared-or-approved-fda-and

rss-es

Baxter Issues Urgent Safety Communication to Reinforce Important Safety Information Regarding Upstream Occlusion Alarms for all Spectrum V8 and Spectrum IQ Infusion Pumps

Murilo Freitas - 05:00, 17 de febrero de 2022489

Baxter International Inc. announced today it has issued an Urgent Safety Communication to reinforce important safety information regarding upstream occlusion alarms for all Spectrum V8 and Spectrum IQ infusion pumps. Incorrect administration set setup and/or incomplete resolution of upstream occlusi

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-urgent-safety-communication-reinforce-important-safety-information-regarding-upstream